This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A systematic review and meta-analysis of neuromodulation therapies for substance use disorders
Neuropsychopharmacology Open Access 12 December 2023
-
Deep Brain Stimulation for Addictive Disorders—Where Are We Now?
Neurotherapeutics Open Access 11 April 2022
-
Drug addiction: from bench to bedside
Translational Psychiatry Open Access 12 August 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kuhn J, Lenartz D, Huff W, Lee S, Koulousakis A, Klosterkoetter J et al J Neurol Neurosurg Psychiatry 2007; 78: 1152–1153.
Zhou H, Xu J, Jiang J . Biol Psychiatry 2011; 69: e41–e42.
Kuhn J, Grundler TO, Bauer R, Huff W, Fischer AG, Lenartz D et al Addict Biol 2011; 16: 620–623.
Luigjes J, van den Brink W, Feenstra M, van den Munckhof P, Schuurman PR, Schippers R et al Mol Psychiatry 2012; 17: 572–583.
Sinha R, Catapano D, O‘Malley S . Psychopharmacology (Berl) 1999; 142: 343–351.
Bewernick BH, Kayser S, Sturm V, Schlaepfer TE . Neuropsychopharmacology 2012; 37: 1975–1985.
Pascoli V, Turiault M, Luscher C . Nature 2012; 481: 71–75.
Denys D, Mantione M, Figee M, van den Munckhof P, Koerselman F, Westenberg H et al Arch Gen Psychiatry 2010; 67: 1061–1068.
Stephen JH, Halpern CH, Barrios CJ, Balmuri U, Pisapia JM, Wolf JA et al Addiction 2012; 107: 624–634.
Pukrop R, Moller HJ, Steinmeyer EM . Eur Arch Psychiatry Clin Neurosci 2000; 250: 120–132.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Möller M, Treppmann JF, Bartsch C, Gruendler TOJ, Brosig A, Barnikol UB and Klosterkötter J declare no conflict of interest. Kuhn J has occasionally received honoraria from AstraZeneca, Lilly, Lundbeck and Otsuka Pharma for lecturing at conferences and financial support to travel. Kuhn J received financial support for IIT-DBS studies (not the present investigation) from Medtronic GmbH (Meerbusch, Germany). Lenartz D reports having received financial assistance for travel to congresses from Medtronic AG. Maarouf M has occasionally received honoraria from Medtronic for lecturing at conferences and consulting. Strum V disclosed financial support for studies and travel to congresses, and lecture fees from Medtronic AG and Advanced Neuromodulation Systems INC. He also reported to be a co-holder of patents on desynchronized brain stimulation and shareholder of ANM-GmbH Jülich, a company that intends to develop new stimulators.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Kuhn, J., Möller, M., Treppmann, J. et al. Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction. Mol Psychiatry 19, 145–146 (2014). https://doi.org/10.1038/mp.2012.196
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2012.196
This article is cited by
-
A systematic review and meta-analysis of neuromodulation therapies for substance use disorders
Neuropsychopharmacology (2024)
-
The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex
Neuropsychopharmacology (2022)
-
Deep Brain Stimulation for Addictive Disorders—Where Are We Now?
Neurotherapeutics (2022)
-
Drug addiction: from bench to bedside
Translational Psychiatry (2021)
-
Outcomes of deep brain stimulation surgery for substance use disorder: a systematic review
Neurosurgical Review (2021)